Condition: Bipolar-I Disorder With Mania or Mania With Mixed Features · Sponsor: Bristol-Myers Squibb
The purpose of this study is to evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolar-I Disorder
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 0058 | Bentonville, Arkansas, United States | Active Not Recruiting |
| Woodland International Research Group | Little Rock, Arkansas, United States | Recruiting |
| Advanced Research Center Inc. | Anaheim, California, United States | Recruiting |
| CITrials | Bellflower, California, United States | Recruiting |
| Local Institution - 0014 | Cerritos, California, United States | Not Yet Recruiting |
| Collaborative Neuroscience Research, LLC | Long Beach, California, United States | Recruiting |
| NRC Research Institute | Los Angeles, California, United States | Recruiting |
| Catalina Research Institute, LLC | Montclair, California, United States | Recruiting |
| Connecticut Mental Health Center | New Haven, Connecticut, United States | Recruiting |
| Research Centers of America ( Hollywood ) | Hollywood, Florida, United States | Recruiting |
| Advanced Research Institute of Miami | Homestead, Florida, United States | Recruiting |
| South Florida Research Phase I-IV | Miami, Florida, United States | Recruiting |
+ 61 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06951698